Energy shares lead broad rebound on Wall Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Francesca\'s Holdings (FRAN) PT Lowered to $8 at FBR Capital Following 2Q
September 6, 2017 1:40 PM EDTFBR Capital lowered its price target on Francesca\'s Holdings (NASDAQ: FRAN) to $8.00 (from $10.00) while maintaining a Neutral rating following the company's 2Q earnings release. FRAN reported EPS of $0.20, versus the consensus estimate of $0.19. Management guided 3Q17 well below the Street due to... More
Sarepta (SRPT) Could See Exon 53 Approval in 2018, Peak Sales of ~$800M - William Blair
September 6, 2017 11:06 AM EDTWilliam Blair analyst Tim Lugo weighed in on Sarepta Therapeutics (NASDAQ: SRPT) after the company announced positive interim 48-week data from its ongoing European Phase I/II study for DMD patients amenable to skipping exon 53 with golodirsen (SRP-4053).
Lugo notes all... More
UPDATE: Sarepta Therapeutics (SRPT) PT Raised to $55 at Piper Jaffray
September 6, 2017 10:57 AM EDT(Updated - September 6, 2017 11:00 AM EDT)
(updated to add analyst comment)
Piper Jaffray raised its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $55.00 (from $50.00) while maintaining a Overweight rating.
Analyst Edward Tenthoff notes the positive Exon 53 data. The analyst further comments... More
HP Enterprise (HPE) PT Lowered to $14 at Susquehanna Following 3Q
September 6, 2017 8:10 AM EDTSusquehanna lowered its price target on HP Enterprise (NYSE: HPE) to $14.00 (from $17.00) while maintaining a Neutral rating following the company's 3Q earnings report. HPE delivered Jul Q revenues and EPS of $8.2B and $0.30 vs. the consensus of $7.5B/$0.26.
HPE's Oct Q guidance of $0.28 is below... More
